Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 21, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Robert Driscoll Reiterated (TYRA) at Buy and Held Target at $28 on, Mar 21st, 2024
Robert Driscoll of Wedbush, Reiterated "Tyra Biosciences, Inc." (TYRA) at Buy and Held Target at $28 on, Mar 21st, 2024.
Robert has made no other calls on TYRA in the last 4 months.
There is 1 other peer that has a rating on TYRA. Out of the 1 peers that are also analyzing TYRA, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $23 on, Wednesday, March 20th, 2024
